Sam Brusco, Associate Editor06.22.22
Vektor Medical, developer of technology to non-invasively map arrhythmias in all four heart chambers, has promoted president and COO Rob Krummen to CEO. Mike Monko, who has served as CEO for the past five years, will continue as executive chairman of Vektor’s board of directors.
Krummen has almost two decades of experience leading and advising corporations, nonprofits, higher education institutions, and state entities. Before joining Vektor in 2018, he helped manage the most profitable division of a former Fortune 500 company. He was also a former partner at Vorys, Sater, Seymour and Pease LLP and a former deputy solicitor general for the state of Ohio.
Vektor is transitioning to a commercial company and focusing on the pilot launch of the vMapnon-invasive cardiac arrhythmia mapping platform at select cardiovascular centers across the U.S.
“Vektor Medical has a unique opportunity to revolutionize the standard of care for arrhythmias, and I look forward to working hard alongside our brilliant team to bring this technology to many more people suffering from serious heart rhythm disorders,” Krummen told the press. “I’m incredibly thankful for Mike's leadership. As a co-founder of Vektor, he understood the power of Vektor’s mapping technology, and helped bring it to hundreds of cardiac arrhythmia cases. I’m thrilled to build upon the foundation he set and to lead Vektor during this exciting time of commercial expansion.”
“It’s been an honor to lead Vektor through the development and launch of our first product. I’ve worked side by side with Rob these last four years and I am confident in his leadership as he takes Vektor into this next phase of growth,” said Monko. “I remain committed to partnering with the team to improve outcomes in cardiac patient care.”
Krummen has almost two decades of experience leading and advising corporations, nonprofits, higher education institutions, and state entities. Before joining Vektor in 2018, he helped manage the most profitable division of a former Fortune 500 company. He was also a former partner at Vorys, Sater, Seymour and Pease LLP and a former deputy solicitor general for the state of Ohio.
Vektor is transitioning to a commercial company and focusing on the pilot launch of the vMapnon-invasive cardiac arrhythmia mapping platform at select cardiovascular centers across the U.S.
“Vektor Medical has a unique opportunity to revolutionize the standard of care for arrhythmias, and I look forward to working hard alongside our brilliant team to bring this technology to many more people suffering from serious heart rhythm disorders,” Krummen told the press. “I’m incredibly thankful for Mike's leadership. As a co-founder of Vektor, he understood the power of Vektor’s mapping technology, and helped bring it to hundreds of cardiac arrhythmia cases. I’m thrilled to build upon the foundation he set and to lead Vektor during this exciting time of commercial expansion.”
“It’s been an honor to lead Vektor through the development and launch of our first product. I’ve worked side by side with Rob these last four years and I am confident in his leadership as he takes Vektor into this next phase of growth,” said Monko. “I remain committed to partnering with the team to improve outcomes in cardiac patient care.”
